Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
Authors
Keywords
-
Journal
PROSTATE
Volume 73, Issue 2, Pages 113-120
Publisher
Wiley
Online
2012-06-06
DOI
10.1002/pros.22546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion
- (2012) Maciej Salagierski et al. JOURNAL OF UROLOGY
- Management of Rising Prostate-specific Antigen After a Negative Biopsy
- (2011) David A. Levy et al. Current Urology Reports
- Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development
- (2010) Jack A. Schalken EUROPEAN UROLOGY
- External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
- (2010) Monique J. Roobol et al. EUROPEAN UROLOGY
- PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
- (2010) Sheila M.J. Aubin et al. JOURNAL OF UROLOGY
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Urine biomarkers in prostate cancer
- (2010) Guillaume Ploussard et al. Nature Reviews Urology
- What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema
- (2010) Adam S. Ptolemy et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
- (2009) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
- (2009) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
- Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
- (2008) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy
- (2008) Jean-Louis Campos-Fernandes et al. EUROPEAN UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started